Amerigen Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Amerigen Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10653
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amerigen Pharmaceuticals Ltd (Amerigen Pharmaceuticals) is a pharmaceutical product manufacturer that develops, markets pharmaceutical products. The company’s portfolio consists of products under development that are filed or anticipated to be filed as abbreviated new drug application with the Chinese CFDA and the US FDA. It focuses on developing orally delivered products with specific technology and complex regulatory and intellectual property issues. Amerigen Pharmaceuticals develops drugs in collaboration with various pharmaceutical companies. The company operates through its subsidiaries in Lyndhurst, New Jersey, the US and Suzhou, Jiangsu Province and China, among others. Amerigen Pharmaceuticals is headquartered in Lyndhurst, New Jersey, the US.

Amerigen Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Amerigen Pharma and Biophore India Pharma Enter into Agreement 10
Amerigen Pharma Enters into Co-Development Agreement with Ningbo Menovo Pharma 11
Amerigen Pharma Enters Into Co-Development Agreement With Forest Labs For Specialty Generic Products 12
Amerigen Pharma Enters Into Co-Development Agreement With Shanghai Fosun Omni Pharma 13
Amerigen Pharma And VIWA Pharma Enter Into JV To Develop And Sell Generics In China 14
Equity Offering 15
Amerigen Pharma to Raise USD35 Million in Private Placement of Shares 15
Amerigen Pharma Raises USD35 Million in Private Placement of Shares 16
Amerigen Pharmaceuticals Ltd – Key Competitors 17
Amerigen Pharmaceuticals Ltd – Key Employees 18
Amerigen Pharmaceuticals Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amerigen Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amerigen Pharma and Biophore India Pharma Enter into Agreement 10
Amerigen Pharma Enters into Co-Development Agreement with Ningbo Menovo Pharma 11
Amerigen Pharma Enters Into Co-Development Agreement With Forest Labs For Specialty Generic Products 12
Amerigen Pharma Enters Into Co-Development Agreement With Shanghai Fosun Omni Pharma 13
Amerigen Pharma And VIWA Pharma Enter Into JV To Develop And Sell Generics In China 14
Amerigen Pharma to Raise USD35 Million in Private Placement of Shares 15
Amerigen Pharma Raises USD35 Million in Private Placement of Shares 16
Amerigen Pharmaceuticals Ltd, Key Competitors 17
Amerigen Pharmaceuticals Ltd, Key Employees 18
Amerigen Pharmaceuticals Ltd, Subsidiaries 19

List of Figures
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Amerigen Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • MilliporeSigma:企業の戦略的SWOT分析
    MilliporeSigma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Blade Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Blade Therapeutics Inc (Blade Therapeutics) is a biopharmaceutical company which develops novel anti-fibrotic therapies to treat various fibrotic disorders. Its lead program is a small molecule inhibitor targeting an intracellular cysteine protease associated with fibrosis across diverse ind …
  • Theravance Biopharma Inc (TBPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Theravance Biopharma Inc (Theravance Biopharma) is a diversified biopharmaceutical company. Its flagship product, Vibativ (telavancin) is a bactericidal, once-daily injectable antibiotic to treat patients with serious, life-threatening infections due to Staphylococcus aureus and other Gram-p …
  • Canadian Utilities Ltd (CU):電力:M&Aディール及び事業提携情報
    Summary Canadian Utilities Ltd (CUL), an ATCO company, is an electric utility. The company carries out electricity and natural gas distribution and transmission operations. It constructs and maintains electrical transmission and distribution lines and has stakes in generating plants through subsidia …
  • Vitasoy International Holdings Ltd.:企業の戦略・SWOT・財務分析
    Vitasoy International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vitasoy International Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Centric Health Corp (CHH):製薬・医療:M&Aディール及び事業提携情報
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • NicozDiamond Insurance Limited:企業の戦略・SWOT・財務情報
    NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Koei Tecmo Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mineworx Technologies Ltd:企業の戦略・SWOT・財務分析
    Mineworx Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Mineworx Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • FieldPoint Petroleum Corp (FPPP):石油・ガス:M&Aディール及び事業提携情報
    Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working interests in exploration areas. Its properties comprise South Vacuum field, Block A-49 and Block 6 field, Fly …
  • Ssr Mining Inc:企業の戦略・SWOT・財務分析
    Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The National Petrochemical Co:企業の戦略的SWOT分析
    The National Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • CorEnergy Infrastructure Trust Inc (CORR):石油・ガス:M&Aディール及び事業提携情報
    Summary CorEnergy Infrastructure Trust Inc (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its portf …
  • OraMetrix Inc-医療機器分野:企業M&A・提携分析
    Summary OraMetrix Inc (OraMetrix) is a healthcare technology company that provides 3-D technology solutions. The company offers orthodontic treatment system and digital lingual orthodontic system. Its product allows the use of precision digital tools throughout the orthodontic treatment process incl …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TC Pipelines LP (TCP):石油・ガス:M&Aディール及び事業提携情報
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • Biomatrica Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biomatrica Inc (Biomatrica) is a biological stabilization products developer that offers healthcare technology products. The company offers assay design and use; omics sample collection, and transport and storage chemistry products. Its transport and storage chemistry products comprise custo …
  • Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Neon Therapeutics Inc (Neon Therapeutics) is a clinical-stage immuno-oncology company that focuses on the development of neoantigen-based therapeutics for the treatment of cancer. The company pipeline product portfolio comprises NEO-PV-01, a personal neoantigen vaccine; NEO-PTC-01, a persona …
  • Axel Springer SE:企業のM&A・事業提携・投資動向
    Axel Springer SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Axel Springer SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆